6Antman EM, Wiviott SD, Murphy SA, et al. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing pereuta- neous coronary intervention: a TRION -TIMI38 (trial to assess improve- ment in therpeutic outcomes by optimizing platelet inhibition with prasug- re1- thrombolysis in myocardial infarction) analysis [J] . J Am Coll Cardiol, 2008, 51 (21) : 2028 -2033.
7King M, Jones L, McCarthy O, et al. Development and pilot evaluation of a complex intervention to improve experienced continuity of care in pa- tients with cancer [J] . Br Cancer, 2009, 100 (2) : 274 -280.
8Moran A, Zhao D, Gu DF, et al. The future impact of population growth and aging on coronary heart disease in China: Projections from the coro- nary heart disease policy model China [J] . BMC Public Health, 2012, 12 (8) : 394 -398.
10Ogawa H, Nakayanm M, Morimoto T, et al. Low - dose aspirin for pri- mary prevention of atherosclerotic events in patients with type 2 diabe- tes: a randomized controlled trial [J] . JAMA, 2008, 300 (18) : 2134 -2141.
